SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
EDAP TMS S.A. Submits U.S. FDA Pre-Market Approval Application for Ablatherm®-HIFU for Treatment of Low Risk, Localized Prostate Cancer